Skip to main content
Top
Published in: Rheumatology International 7/2014

01-07-2014 | Short Communication

An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus

Authors: Etheresia Pretorius, Jenny du Plooy, Prashilla Soma, Armen Yuri Gasparyan

Published in: Rheumatology International | Issue 7/2014

Login to get access

Abstract

The study suggests that patients with systemic lupus erythematosus (SLE) present with distinct inflammatory ultrastructural changes such as platelets blebbing, generation of platelet-derived microparticles, spontaneous formation of massive fibrin network and fusion of the erythrocytes membranes. Lupoid platelets actively interact with other inflammatory cells, particularly with white blood cells (WBCs), and the massive fibrin network facilitates such an interaction. It is possible that the concerted actions of platelets, erythrocytes and WBC, caught in the inflammatory fibrin network, predispose to pro-thrombotic states in patients with SLE.
Literature
2.
go back to reference Swadzba J, Iwaniec T, Musial J (2011) Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state. Rheumatol Int 31(3):307–313. doi:10.1007/s00296-009-1314-8 PubMedCrossRef Swadzba J, Iwaniec T, Musial J (2011) Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state. Rheumatol Int 31(3):307–313. doi:10.​1007/​s00296-009-1314-8 PubMedCrossRef
4.
go back to reference Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8(4):437–449. doi:10.2174/157016110791330852 PubMedCrossRef Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8(4):437–449. doi:10.​2174/​1570161107913308​52 PubMedCrossRef
5.
go back to reference Mashhadi MA, Bari Z (2011) Thrombotic thrombocytopenic purpura and deep vein thrombosis as the presenting manifestations of systemic lupus erythematosus: a case report and review of literature. J Res Med Sci 16(8):1082–1088PubMedCentralPubMed Mashhadi MA, Bari Z (2011) Thrombotic thrombocytopenic purpura and deep vein thrombosis as the presenting manifestations of systemic lupus erythematosus: a case report and review of literature. J Res Med Sci 16(8):1082–1088PubMedCentralPubMed
7.
go back to reference Satoh T, Tanaka Y, Okazaki Y, Kaburaki J, Ikeda Y, Kuwana M (2012) Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus. Rheumatology (Oxford) 51(9):1721–1728. doi:10.1093/rheumatology/kes145 CrossRef Satoh T, Tanaka Y, Okazaki Y, Kaburaki J, Ikeda Y, Kuwana M (2012) Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus. Rheumatology (Oxford) 51(9):1721–1728. doi:10.​1093/​rheumatology/​kes145 CrossRef
10.
go back to reference Spengler MI, Svetaz MJ, Leroux MB, Bertoluzzo SM, Carrara P, Van Isseldyk F, Petrelli D, Parente FM, Bosch P (2011) Erythrocyte aggregation in patients with systemic lupus erythematosus. Clin Hemorheol Microcirc 47(4):279–285. doi:10.3233/CH-2011-1409 PubMed Spengler MI, Svetaz MJ, Leroux MB, Bertoluzzo SM, Carrara P, Van Isseldyk F, Petrelli D, Parente FM, Bosch P (2011) Erythrocyte aggregation in patients with systemic lupus erythematosus. Clin Hemorheol Microcirc 47(4):279–285. doi:10.​3233/​CH-2011-1409 PubMed
11.
go back to reference Ghiran IC, Zeidel ML, Shevkoplyas SS, Burns JM, Tsokos GC, Kyttaris VC (2011) Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production. Arthritis Rheum 63(2):503–512. doi:10.1002/art.30143 PubMedCentralPubMedCrossRef Ghiran IC, Zeidel ML, Shevkoplyas SS, Burns JM, Tsokos GC, Kyttaris VC (2011) Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production. Arthritis Rheum 63(2):503–512. doi:10.​1002/​art.​30143 PubMedCentralPubMedCrossRef
12.
go back to reference Midgley A, McLaren Z, Moots RJ, Edwards SW, Beresford MW (2009) The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 60(8):2390–2401. doi:10.1002/art.24634 PubMedCrossRef Midgley A, McLaren Z, Moots RJ, Edwards SW, Beresford MW (2009) The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 60(8):2390–2401. doi:10.​1002/​art.​24634 PubMedCrossRef
15.
17.
19.
go back to reference Nielsen CT, Østergaard O, Johnsen C, Jacobsen S, Heegaard NH (2011) Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum 63(10):3067–3077. doi:10.1002/art.30499 PubMedCrossRef Nielsen CT, Østergaard O, Johnsen C, Jacobsen S, Heegaard NH (2011) Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum 63(10):3067–3077. doi:10.​1002/​art.​30499 PubMedCrossRef
Metadata
Title
An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus
Authors
Etheresia Pretorius
Jenny du Plooy
Prashilla Soma
Armen Yuri Gasparyan
Publication date
01-07-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 7/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2817-x

Other articles of this Issue 7/2014

Rheumatology International 7/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.